30 Day Trial

NuVasive Reports 1Q16 Revenue

Share:

NuVasive reported 1Q16 revenue of US $215.1MM, +11.8% from 1Q15. (U.S. $186.4MM, +11.1%; ex-U.S. $28.7MM, +16.7%) All growth is as reported.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.